Search

everythinglearnresearchcommunity

for

Search:↓

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Acne is an important sign of androgen excess disorders in women.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Spironolactone may help reduce hair loss in androgenic alopecia.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

The document concludes that various treatments, including laser therapy, are effective for managing pseudofolliculitis barbae, especially in darker skin types.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

The review concluded that male pattern baldness is mostly seen negatively, affecting attractiveness and social appeal.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.